Integrating Structured Expert Elicitation with External Evidence to Inform Earlier Reimbursement Decisions: A Norwegian Case Study of Selpercatinib for Non-Small Cell Lung Cancer.

Saved in:
Bibliographic Details
Title: Integrating Structured Expert Elicitation with External Evidence to Inform Earlier Reimbursement Decisions: A Norwegian Case Study of Selpercatinib for Non-Small Cell Lung Cancer.
Authors: Wu YS; Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway. yansiw@medisin.uio.no., Burger EA; Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway.; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA, USA., Holmboe F; AbbVie, Oslo, Norway., Bangum M; AbbVie, Oslo, Norway., Oteiza F; Oslo Economics, Oslo, Norway., Bugge C; Oslo Economics, Oslo, Norway., Sæther EM; Oslo Economics, Oslo, Norway., Aas E; Department of Health Management and Health Economics, Institute of Health and Society, University of Oslo, Oslo, Norway.; Division for Health Services, Norwegian Institute of Public Health, Oslo, Norway.
Source: PharmacoEconomics - open [Pharmacoecon Open] 2026 Jul; Vol. 10 (4), pp. 679-694. Date of Electronic Publication: 2026 Jun 18.
Publication Type: Journal Article
Journal Info: Publisher: Springer International Publishing AG Country of Publication: Switzerland NLM ID: 101700780 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2509-4254 (Electronic) Linking ISSN: 25094262 NLM ISO Abbreviation: Pharmacoecon Open Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2509-4254
DOI:10.1007/s41669-026-00656-9